Lv62
2190 积分 2024-08-22 加入
FDA Experience on CAR T Cell Pharmacokinetics/Pharmacodynamics and Model‐Based Assessments
1小时前
待确认
Tabelecleucel: First Approval
6天前
已完结
Application of Novel Drug‐Delivery Strategies in Neurological Disorders
6天前
已完结
嵌合抗原受体T细胞治疗：难治性神经系统自身免疫性疾病的曙光
6天前
已完结
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology
6天前
已完结
中国重症肌无力诊断和治疗指南（2025版）
19天前
已完结
The rise of China’s pharmaceutical industry from 2015–2024: a decade of innovation
19天前
已完结
beta-Propiolactone: viral inactivation in vaccines and plasma products
24天前
已完结
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
1个月前
已完结
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST
1个月前
已完结
皖公网安备34019202002308
